A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD)
Public ClinicalTrials.gov record NCT05376176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase IIa, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) - PHANTOM Study
Study identification
- NCT ID
- NCT05376176
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Santen Inc.
- Industry
- Enrollment
- 86 participants
Conditions and interventions
Conditions
Interventions
- STN1010904 ophthalmic suspension 0.03% BID Drug
- STN1010904 ophthalmic suspension 0.1% BID Drug
- Placebo (Vehicle) BID Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 18, 2022
- Primary completion
- May 25, 2025
- Completion
- May 25, 2025
- Last update posted
- Jul 14, 2025
2022 – 2025
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stein Eye Institution UCLA | Los Angeles | California | 90095 | — |
| Price Vision Group | Indianapolis | Indiana | 46260 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Tauber Eye Center | Kansas City | Missouri | 64111 | — |
| Comprehensive Eye Care, Ltd | Washington | Missouri | 63090 | — |
| Metropolitan Eye Research and Surgery Center | Palisades Park | New Jersey | 07650 | — |
| Devers Eye Institute | Portland | Oregon | 97210 | — |
| Scott Christie and Associates | Cranberry Township | Pennsylvania | 16066 | — |
| UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| Houston Eye Associates | Houston | Texas | 77025-1697 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05376176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05376176 live on ClinicalTrials.gov.